Clinical Trials Logo
  1. Home
  2. Dumping Syndrome
  3. NCT05759689

Fat Supplementation on Dumping Syndrome Related Symptoms After Gastric Surgery

Dumping Syndrome Clinical Trial

Official title:
The Effect of Fat Supplementation on the Appearance of Symptoms Associated With Dumping Syndrome in Patients Undergone Gastric Surgery

Clinical Trial Summary

The purpose of the study is the investigation of the effect of fat supplement on gastric emptying rate and the appearance of symptoms of Dumping Syndrome in patients who have undergone gastrointestinal- duodenal surgery. Patients who have undergone bariatric surgery have been examined for the presence of the Dumping syndrome, with glucose measurements, the Sigstad's questionnaire and questionnaire of Arts. Patients diagnosed positive, reiterated the examination process in a second meeting consuming an extra fat supplement. The data obtained on the different appointments were compared between the two groups in a cross over design.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05759689
Study type Interventional
Source Larissa University Hospital
Contact ATHANASIOS MIGDANIS
Phone 6973240203
Email thanmig@yahoo.com
Status Recruiting
Phase N/A
Start date September 28, 2021
Completion date September 2024
View Details
See also
  Status Clinical Trial Phase
Recruiting NCT04028193 - Fat Supplementation on Dumping Syndrome Associated Symptoms N/A
Recruiting NCT00543179 - Treatment of the Dumping Syndrome With Lanreotide Autogel® Phase 4
Not yet recruiting NCT04522193 - Dumping Syndrome and Esophageal Atresia N/A
Completed NCT02891330 - Impact of an Educational Personalized Clinical Support Device Preventive and a Referent Nurse in Surgery for Obesity N/A
Completed NCT02525705 - Dumping Syndrome After Operation of Esophageal Atresia Type III N/A
Completed NCT01794793 - Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Studies Phase 4
Completed NCT03734627 - Gastrointestinal Nutrient Transit and Enteroendocrine Function After Upper Gastrointestinal Surgery
Terminated NCT02836353 - Metabolic Consequences of Gastrointestinal Surgery N/A
Completed NCT05057819 - Investigating the Impact of the SGLT2 Inhibitor Empagliflozin on Postprandial Hypoglycaemia After Gastric Bypass Phase 4
Completed NCT02971631 - Gastrectomy, Eating Behaviour and GLP-1 N/A
Completed NCT01923649 - SOMATULINE Autogel 90 mg IN DUMPING SYNDROME Phase 2